EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2016 first quarter, ended December 31, 2015.
“The SurModics team had an exceptional first quarter of fiscal 2016”
“The SurModics team had an exceptional first quarter of fiscal 2016,” said Gary Maharaj, president and chief executive officer.
“The SurModics team had an exceptional first quarter of fiscal 2016”
“The SurModics team had an exceptional first quarter of fiscal 2016,” said Gary Maharaj, president and chief executive officer.
